HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
MPT0B292
selectively acetylates alpha-tubulin in cells; has antineoplastic properties
Networked:
1
relevant articles (
0
outcomes,
0
trials/studies)
Bio-Agent Context: Research Results
Polycyclic Compounds: 6
MPT0B292: 1
Experts
1.
Chang, Jang-Yang
: 1 article (07/2017)
2.
Huang, Jin-Ding
: 1 article (07/2017)
3.
Li, Chan-Jung
: 1 article (07/2017)
4.
Liou, Jing-Ping
: 1 article (07/2017)
5.
Tien, Yu-En
: 1 article (07/2017)
Related Diseases
1.
Neoplasms (Cancer)
07/01/2017 - "
MPT0B292 was identified through screening of compounds able selectively to acetylate α-tubulins in cells and it exhibited potent anti-tumor, anti-angiogenesis and anti-metastatic effects in vitro and in vivo.
"